Dan Ripma
Vice President @ S2G Investments
Chicago, United States
Dan Ripma is a Vice President at S2G Ventures. Dan previously worked at BMO Capital Markets as a Investment Banking Summer Analyst. He attended Indiana University Bloomington.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Dan Ripma invests in
Stages Dan Ripma invests in
Countries Dan Ripma invests in
Investment Focus
Industry
- Health Care 3 (60%)
- Software 2 (40%)
- Nutrition 2 (40%)
- SaaS 1 (20%)
- Wellness 1 (20%)
Stage
- Series A 1 (20%)
- Series B 1 (20%)
- Private Equity 1 (20%)
- Venture - Series Unknown 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
MEND
|
MEND is a life sciences company with a mission to help people heal and live their healthiest. The company is currently researching and developing targeted clinical nutrition and medical food interventions to enhance patient outcomes, from injury and surgery to aging and physical performance. MEND has been adopted by numerous hospitals, healthsystems, professional sports teams across all major leagues, and the elite forces of the US Military. The company is headquartered in New York City. | $20M / Series A / Dec 11, 2025 | |
Pyx Health
|
Pyx Health is a mobile solution that reduces loneliness and social isolation. It connects members outside of the traditional care setting. By providing critical and timely interventions and addressing social determinants of health, it takes care of the members when they are most vulnerable, especially after a transition of care.Pyx Health offersPyxir, an endearing chatbot personality that walks alongside your members in their health care journey. Affectionately referred to as ‘he’ by our members, Pyxir promotes healthy interaction within the app by building trusted companionship with its members 24/7.It was founded in 2017 and is headquartered in Tucson, Arizona. | $47.5M / Private Equity / Jun 03, 2025 | |
Mealogic
|
Mealogic offers a platform for businesses to deliver chef-crafted, nutrition-led meals through their end-to-end commerce solution. | $16M / Venture - Series Unknown / Mar 25, 2025 | |
Big Bold Health
|
Big Bold Health® is a platform company providing immune health solutions through nature's wisdom and modern science. | Series B / Jan 16, 2025 | |
|
MEND
|
MEND is a life sciences company with a mission to help people heal and live their healthiest. The company is currently researching and developing targeted clinical nutrition and medical food interventions to enhance patient outcomes, from injury and surgery to aging and physical performance. MEND has been adopted by numerous hospitals, healthsystems, professional sports teams across all major leagues, and the elite forces of the US Military. The company is headquartered in New York City. | $16.5M / Series A / Jun 06, 2023 |
Co-Investors
About S2G Investments
S2G Investments is a multi-stage investment firm that targets venture and growth-stage businesses in food and agriculture, oceans, and energy sectors. The firm provides capital to businesses shaping the future of food systems and energy resources, aiming for significant sector transitions. S2G Investments assist entrepreneurs and leadership groupsin seeking innovative, market-driven solutions aimed at providing increased value, better results, and superior performance compared to conventional options.
S2G Investments Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Arthur Chow
Vice President
|
|||
Cristina Rohr
Managing Director
|
|||
|
Dan Ripma
Vice President
|
|||
Francis O'Sullivan
Managing Director
|
|||
Grant Leslie
Operating Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dan Ripma invest in?
Dan Ripma invests primarily in Health Care, Software and Nutrition startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dan Ripma last invest?
The most recent investment recorded for Dan Ripma closed in Dec 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
